Progress and controversy for the role of chemotherapy in nasopharyngeal carcinoma

作者: T. Yoshizaki , S. Kondo , S. Murono , K. Endo , A. Tsuji

DOI: 10.1093/JJCO/HYU212

关键词:

摘要: Since the publication of Intergroup Study 0099, representing a superiority concurrent chemoradiotherapy with cisplatin followed byadjuvant chemotherapy to radiotherapyalone for treatment locoregionallyadvanced nasopharyngeal carcinoma, an efficacyof setting cisplatinbased radiotherapy has been repeatedly validated. In meanwhile, role adjuvant part protocol controversial. There is increasing evidence positive neoadjuvant following whereas favorable contribution was not proven in last century. This article reviews locoregionally advanced carcinoma.

参考文章(37)
Edward Chow, David Payne, Brian O'Sullivan, Melania Pintilie, Fei Fei Liu, John Waldron, Padraig Warde, Bernard Cummings, Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary? Radiotherapy and Oncology. ,vol. 63, pp. 269- 274 ,(2002) , 10.1016/S0167-8140(02)00132-9
Ye Guo, Ivan W. K. Tham, Jiade Jay Lu, Lin Kong, Chaosu Hu, Xiaoshuang Niu, Youwang Zhang, Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: Interim results from 2 prospective phase 2 clinical trials Cancer. ,vol. 119, pp. 4111- 4118 ,(2013) , 10.1002/CNCR.28324
Snjezana Dogan, Matthew L. Hedberg, Robert L. Ferris, Tanya J. Rath, Adel M. Assaad, Simion I. Chiosea, Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population. Head and Neck-journal for The Sciences and Specialties of The Head and Neck. ,vol. 36, pp. 511- 516 ,(2014) , 10.1002/HED.23318
Jun Ma, Hai-Qiang Mai, Ming-Huang Hong, Hua-Qing Min, Zhi-Da Mao, Nian-Ji Cui, Tai-Xiang Lu, Hao-Yuan Mo, Results of a Prospective Randomized Trial Comparing Neoadjuvant Chemotherapy Plus Radiotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Journal of Clinical Oncology. ,vol. 19, pp. 1350- 1357 ,(2001) , 10.1200/JCO.2001.19.5.1350
Tomokazu Yoshizaki, Makoto Ito, Shigekyuki Murono, Naohiro Wakisaka, Satoru Kondo, Kazuhira Endo, Current understanding and management of nasopharyngeal carcinoma Auris Nasus Larynx. ,vol. 39, pp. 137- 144 ,(2012) , 10.1016/J.ANL.2011.02.012
Jin-Ching Lin, Wen-Yi Wang, Kuang Y. Chen, Yau-Huei Wei, Wen-Miin Liang, Jian-Sheng Jan, Rong-San Jiang, Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma New England Journal of Medicine. ,vol. 350, pp. 2461- 2470 ,(2004) , 10.1056/NEJMOA032260
Sing-fai Leung, Anthony T. C. Chan, Benny Zee, Brigette Ma, Lisa Y. S. Chan, Philip J. Johnson, Y. M. Dennis Lo, Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. Cancer. ,vol. 98, pp. 288- 291 ,(2003) , 10.1002/CNCR.11496
Lei Chen, Chao-Su Hu, Xiao-Zhong Chen, Guo-Qing Hu, Zhi-Bin Cheng, Yan Sun, Wei-Xiong Li, Yuan-Yuan Chen, Fang-Yun Xie, Shao-Bo Liang, Yong Chen, Ting-Ting Xu, Bin Li, Guo-Xian Long, Si-Yang Wang, Bao-Min Zheng, Ying Guo, Ying Sun, Yan-Ping Mao, Ling-Long Tang, Yu-Ming Chen, Meng-Zhong Liu, Jun Ma, Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial Lancet Oncology. ,vol. 13, pp. 163- 171 ,(2012) , 10.1016/S1470-2045(11)70320-5